4.5 Article

Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases

Journal

WORLD JOURNAL OF SURGERY
Volume 41, Issue 8, Pages 2087-2094

Publisher

SPRINGER
DOI: 10.1007/s00268-017-3964-0

Keywords

-

Categories

Ask authors/readers for more resources

Background The aims of this study were to investigate predictive factors for microscopic portal venous invasion (mPVI) in hepatocellular carcinoma (HCC) and whether anatomical liver resection (ALR) was useful in such cases. Methods We analyzed 852 patients with HCC without macroscopic portal venous invasion who were treated at our hospital between January 1990 and May 2014. These patients were stratified into a microscopic portal venous invasion group (mPVI group; n = 153) and non-microscopic portal venous invasion group (NmPVI group; n = 699). Results PIVKA-II >= 100 mAU/ml, a tumor size >= 5 cm, a confluent lesion, and poor differentiation were found to be independent risk factors for mPVI. Among the mPVI group who had single HCC under 5 cm, serum albumin level <4.0 g/dl, PIVKA-II >= 100 mAU/ml, a positive surgical margin, and non-ALR (NALR) were independent unfavorable prognostic factors for overall survival (OS). PIVKA-II >= 100 mAU/ml, a positive surgical margin and NALR were independent unfavorable prognostic factors for relapse-free survival (RFS). ALR was significantly favorable factor for both OS and RFS of the mPVI group who had single HCC under 5 cm. Conclusions Even if no portal venous invasion is detectable in HCC patients preoperatively, a PIVKA-II >= 100 mAU/ml, tumor size >= 5 cm, and a confluent lesion indicate a high risk of mPVI. ALR should be considered for the patients with these characteristics because it is a favorable prognostic factor in these cases with mPVI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers

Kazuki Wakizaka, Hideki Yokoo, Toshiya Kamiyama, Masafumi Ohira, Koichi Kato, Yuki Fujii, Ko Sugiyama, Naoki Okada, Takanori Ohata, Akihisa Nagatsu, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Akinobu Taketomi

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Surgery

Prognoses and Clinicopathological Characteristics for Hepatocellular Carcinoma Originating from the Caudate Lobe After Surgery

Shingo Shimada, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Akihisa Nagatsu, Takanori Ohata, Hirofumi Kamachi, Akinobu Taketomi

WORLD JOURNAL OF SURGERY (2019)

Article Gastroenterology & Hepatology

Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma

Makoto Chuma, Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, Kazuhisa Takeda, Chikara Kunisaki, Katsuaki Ogushi, Satoshi Moriya, Koji Hara, Akito Nozaki, Masaaki Kondo, Hiroyuki Fukuda, Kazushi Numata, Katsuaki Tanaka, Shin Maeda, Naoya Sakamoto

HEPATOLOGY RESEARCH (2019)

Article Surgery

Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization

Shingo Shimada, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Kenji Wakayama, Akihisa Nagatsu, Tatsuhiko Kakisaka, Hirofumi Kamachi, Daisuke Abo, Yusuke Sakuhara, Akinobu Taketomi

BMC SURGERY (2019)

Article Gastroenterology & Hepatology

CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma

Kazuki Wakizaka, Hideki Yokoo, Toshiya Kamiyama, Tatsuhiko Kakisaka, Masafumi Ohira, Michio Tani, Koichi Kato, Yuki Fujii, Ko Sugiyama, Akihisa Nagatsu, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Ryosuke Matsuoka, Akinobu Taketomi

HEPATOLOGY RESEARCH (2020)

Article Oncology

Analysis of the correlation between alterations in N-glycans and invasiveness in liver cancer cell lines

Hidenori Takahashi, Toshiya Kamiyama, Nozomi Hirane, Nozomi Kobayashi, Takeshi Aiyama, Akihisa Nagatsu, Shingo Shimada, Tatsuya Orimo, Tatsuhiko Kakisaka, Moto Fukai, Hideki Yokoo, Hirofumi Kamachi, Shin-Ichiro Nishimura, Akinobu Taketomi

ONCOLOGY REPORTS (2020)

Article Multidisciplinary Sciences

Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis

Takeshi Aiyama, Tatsuya Orimo, Hideki Yokoo, Takanori Ohata, Kanako C. Hatanaka, Yutaka Hatanaka, Moto Fukai, Toshiya Kamiyama, Akinobu Taketomi

PLOS ONE (2020)

Article Oncology

Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition

Kazuki Wakizaka, Toshiya Kamiyama, Kenji Wakayama, Tatsuya Orimo, Shingo Shimada, Akihisa Nagatsu, Hirofumi Kamachi, Hideki Yokoo, Moto Fukai, Nozomi Kobayashi, Tomoko Mitsuhashi, Akinobu Taketomi

ONCOLOGY LETTERS (2020)

Article Gastroenterology & Hepatology

Applicability of the histidine-tryptophan-ketoglutarate solution as a machine perfusion solution for marginal liver grafts

Hiroyoshi Iwata, Naoto Matsuno, Daisuke Ishii, Asuka Toriumi, Masahide Otani, Mizuho Ohara, Hiromichi Obara, Yuji Nishikawa, Hideki Yokoo

Summary: This study compared the use of University of Wisconsin solution and histidine-tryptophan-ketoglutarate solution as machine perfusion solutions for marginal liver grafts. The results showed that histidine-tryptophan-ketoglutarate solution can decrease vascular resistance, reduce shear stress, and protect sinusoid epithelial cells in split-liver grafts.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Medicine, General & Internal

Beneficial Effects of Combined Use of Extracorporeal Membrane Oxygenation and Hypothermic Machine Perfusion in Porcine Donors after Cardiac Death for Liver Transplantation

Hiroyoshi Iwata, Hiromichi Obara, Tetsuya Nakajo, Hiroki Kaneko, Yuga Okazawa, Nur Khatijah Mohd Zin, Hiroki Bochimoto, Makito Ohashi, Yoko Kawada, Mizuho Ohara, Hideki Yokoo, Naoto Matsuno

Summary: This study investigated the benefits of using subnormothermic extracorporeal membrane oxygenation (ECMO) and hypothermic machine perfusion (HMP) in a porcine model of liver transplantation from donors after cardiac death (DCD). The results suggested that the combination of ECMO and HMP could improve the functional outcome of DCD liver grafts.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Laparoscopic Extended Left Lateral Sectionectomy for Hepatocellular Carcinoma in a Patient with Right-Sided Ligamentum Teres: A Case Report and Literature Review

Yuki Adachi, Hiroyuki Takahashi, Tomohiro Yamamoto, Masahiro Hagiwara, Koji Imai, Hideki Yokoo

Summary: This article described a rare case of right-sided ligamentum teres variation, in which the patient underwent laparoscopic hepatectomy. The article emphasized the importance of avoiding injury to the right hepatic vasculature during left lobectomy.

DIAGNOSTICS (2023)

Review Oncology

Lymphoepithelioma-like cholangiocarcinoma not associated with Epstein-Barr virus or hepatitis virus: case report and literature review of 100 reported cases

Yuki Adachi, Hideki Yokoo, Masahiro Hagiwara, Hiroyuki Takahashi, Hiroyoshi Iwata, Tomohiro Takeda, Tomohiro Yamamoto, Koji Imai, Sayaka Yuzawa, Mishie Tanino, Naoto Matsuno

Summary: Lymphoepithelioma-like cholangiocarcinoma is a rare variant of primary liver tumor, which occurs more frequently in Asian women and is strongly associated with EBV and hepatitis viruses. This article describes a case of LEL-CC in a 76-year-old woman not associated with EBV or hepatitis virus.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Article Oncology

Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment

Makoto Chuma, Hideki Yokoo, Atsushi Hiraoka, Kazuhiko Ueda, Takahiro Yokoyama, Kunihiko Tsuji, Noritomo Shimada, Haruki Uojima, Satoshi Kobayashi, Nobuhiro Hattori, Tomomi Okubo, Masanori Atsukawa, Toru Ishikawa, Koichi Takaguchi, Akemi Tsutsui, Hidenori Toyoda, Toshifumi Tada, Yoshinori Saito, Shunji Hirose, Takaaki Tanaka, Kazuhisa Takeda, Masako Otani, Zenjiro Sekikawa, Tsunamasa Watanabe, Hisashi Hidaka, Manabu Morimoto, Kazushi Numata, Tatehiro Kagawa, Michiie Sakamoto, Takashi Kumada, Shin Maeda

Summary: This study evaluated the utility of computed tomography attenuation value (CTav) in predicting tumor necrosis in hepatocellular carcinoma patients who achieved complete response after lenvatinib treatment. The results showed that a CTav threshold of 30.2 HU could identify post-lenvatinib necrosis, and an N30-CTav occupancy rate of >30.6% was a predictor of maintaining complete response.

CURRENT ONCOLOGY (2022)

Article Oncology

Preoperative chemotherapy in colorectal cancer patients with synchronous liver metastasis

Nobuki Ichikawa, Toshiya Kamiyama, Hideki Yokoo, Shigenori Homma, Yoshiaki Maeda, Toshiki Shinohara, Yosuke Tsuruga, Keizo Kazui, Hiroaki Iijima, Tadashi Yoshida, Akinobu Taketomi

MOLECULAR AND CLINICAL ONCOLOGY (2020)

Article Gastroenterology & Hepatology

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting

Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Machiko Umemura, Naoki Kawagishi, Mitsuteru Natsuizaka, Masato Nakai, Kenichi Morikawa, Ken Furuya, Masaru Baba, Yoshiya Yamamoto, Tomoe Kobayashi, Takashi Meguro, Akiyoshi Saga, Takuto Miyagishima, Hideki Yokoo, Toshiya Kamiyama, Akinobu Taketomi, Naoya Sakamoto

JGH OPEN (2020)

No Data Available